Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04675827
Title De-escalation Adjuvant Chemo in HER2+/ER-/Node-neg Early BC Patients Who Achieved pCR After Neoadjuvant Chemo & Dual HER2 Blockade (Decrescendo)
Acronym Decrescendo
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries ISR | FRA | CHE | BEL | AUS


No variant requirements are available.